Company Overview

Update
Founded:
2008
Founders:
Michael Weiser, Jason Stein
Headquarters:
New York, NY
Funding:
$17M
Categories:
Biotechnology

Foresight Biotherapeutics is a drug development company developing therapies to address unmet needs in ophthalmology and otolaryngology.

Description

Update

Foresight Biotherapeutics is a clinical-stage drug development company pioneering novel therapies designed to address significant unmet needs in ophthalmology and otolaryngology.

Foresight’s platform Povidone-Iodine (PVP-I) technology represents an important breakthrough in the treatment of ocular and otic inflammation including bacterial, viral and fungal infections. This platform enables PVP-I, a well-characterized broad spectrum antiseptic with no known microbial resistance, to be formulated in combination with a range of anti-inflammatory agents.

Current Team (3)

Update

Funding Rounds (2) - $17M

Update

Offices/Locations (1)

Update
  • Office

    50 West 57th Street

    15th Floor

    New York, NY 10019

    USA

Images (1)

Update
  • D28f818d042bf335dd6d1be7ffaa84d8